Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Levobupivacaine Scalp block
Conventional analgesic therapy
Locations
1
Qatar
Hamad Medical Corporation
Doha, Qatar
Start Date
October 22, 2025
Primary Completion Date
July 30, 2026
Completion Date
December 30, 2026
Last Updated
December 29, 2025
NCT07071506
NCT04715685
NCT05334927
NCT07160088
NCT04939922
NCT05418218
Lead Sponsor
Hamad Medical Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions